Compare Cloudflare Inc (NET) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cloudflare Inc vs Repligen Corporation Common Stock — how do they compare? Cloudflare Inc trades at $318.01 (market cap $123.81B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Cloudflare Inc is far larger — about 11.1× Repligen Corporation Common Stock's market cap, and Cloudflare Inc is more actively traded (1,745,042 versus 1,259,263). Which is the better fit depends on your goals — on Pluang, investors hold Cloudflare Inc for 61 Days and Repligen Corporation Common Stock for 0 Days on average.
| NET | RGEN | |
|---|---|---|
Market Cap | $123.81B | $11.14B |
Volume | 1,745,042 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $361.00 | $194.57 |
52-Week Low | $160.16 | $102.87 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $123.18B | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cloudflare (NET) trades at $324.01, down 7.6% over 24 hours, amid a mixed technical and fundamental backdrop. The stock shows a bullish moving average signal but neutral oscillators, with key support at $328. Fundamentally, revenue growth is strong, reaching $2.17B in 2025, but profitability remains a challenge with a net income margin of -8.21%. Recent news highlights product launches like Cloudflare Basin and a partnership with Deutsche Telekom, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst consensus and strategic initiatives, but high valuation multiples and persistent losses pose risks. Investment opportunity lies in continued top-line expansion and market share gains, while key risks include competitive pressures and execution on path to profitability.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
